T HE natural history of ruptured berry aneurysms is fairly well known and has recently been reviewed in some detail, s The results reported by Richardson and Hyland, 13 Hamby, 4 Ask-Upmark and Ingvar, 1 Pakarinen, x~ and the Cooperative Study ~,1~ are remarkably uniform. It might be stated from these that 50% of patients die within their first hospitalization, and 25% or more of the survivors might be expected to die from recurrent hemorrhage within 10 years. One-half of those who die in the first hospitalization die of rebleeding. Clinical deterioration due to spasm and rebleeding both reach a peak about the end of the first week or the beginning of the second. In 1953, Norl6n and Olivecrona ix reported a mortality of less than 4% in those patients who were surgically treated between 3 and 4 weeks after hemorrhage. This unfortunately did not take care of those who died during the peak of rebleeding. Others, operating before the peak in order to prevent it, sustained an unacceptable mortality because their effort coincided with the concomitant peak of cerebral spasm and clinical deterioration. A basic conflict lay, therefore, between the desire to undertake early surgery in order to prevent death from rebleeding and the desire to delay surgery in order to make surgery safer.
In a previous study we undertook early surgery on 61 patients, using a stereotaxic technique of minimal cerebral invasion. We found it was technically possible to thrombose the neck of most aneurysms by electric needles, but there were problems of spasm, of excess thrombosis, and of incomplete thrombosis. It was believed that with experience and selectivity the results could be improved but that increasing selectivity would leave too many unselected patients without protection. 7 At the same time attention was turned to the development and improvement of methods designed to minimize rebleeding while the patient improved sufficiently to tolerate craniotomy without complication. The earlier results of this study have been reported; 6,8,9 the present report represents the current state of development of these efforts.
Clinical Material
Of 103 consecutive unselected patients with supratentorial (non-giant) aneurysms and a recent subarachnoid hemorrhage (SAH), six were moribund on admission and soon died. The diagnosis was confirmed by autopsy. Thus there were 97 patients, who, at the point of admission, appeared to have some chance of survival. The diagnosis of aneurysm was confirmed by angiography. The patient population was not remarkable, and was drawn from both inner city and suburbs. The former arrived on the day of hemorrhage, the latter some days later. Those managed medically elsewhere are included in a separate category of elective admissions. There were 35 males and 62 females, with ages ranging from 18 to 67 years. Twenty-eight had a previous history of hypertension. Fifty-four were considered to be in Grades 1 and 2 and 43 were in Grades 3 and 4 of a five-grade classification; the six moribund patients were in Grade 5. The aneurysm that was thought to have bled was on the internal carotid artery in 50, on the anterior cerebral artery in 32, and on the middle cerebral artery in 15. In 24 patients the aneurysms were multiple.
The basis of preoperative treatment was pulmonary support when required, antifibrinolysis, controlled hypotension, and controlled intracranial pressure (ICP). On this regimen 25 patients deteriorated by the equivalent of at least one clinical grade from their state on admission. This generally coincided with what has come to be regarded as the period of spasm, being most intense about the end of the first week but often lasting several weeks. It was occasionally associated with such complications as gastrointestinal hemorrhage and pulmonary embolism. Of these 25 patients, 16 improved and survived, and nine died. In addition, six patients rebled and died. There was no clearly documented non-fatal rebleeding, although some instances were possible (Table 1) .
Elective craniotomy and definitive treatment of the aneurysm was considered when the patient was well recovered from his recent hemorrhage, had reached a stable clinical state, and was regarded generally and neurologically as being a good surgical risk. Of the 82 survivors of the conservative regime, 13 did not have this elective intracranial surgery. Three refused, and four were too old or remained too ill by the time (arbitrarily 6 weeks) that the major initial risk of rebleeding had passed. Four, with multiple aneurysms on the same side, were electively treated by complete common carotid occlusion. One patient had only one patent carotid artery. Interestingly, her anterior communicating aneurysm had spontaneously disappeared by the time her 6-month follow-up angiogram was taken. In one patient the presumed anterior communicating aneurysm was poorly defined and remained poorly defined at angiography 6 weeks later.
The remaining 69 had elective intracranial surgery. There was no mortality. Three developed hemiplegia; two made a complete recovery, and one recovered complete function in the leg, but still has some weakness in her left hand. During the same time interval, 33 other patients had elective treatment for similar supratentorial non-giant aneurysms. They included those who had initial conservative management in other institutions, those who presented with a cranial nerve palsy, those who returned to our institution for elective treatment of a non-symptomatic aneurysm (one of multiple aneurysms) discovered at the time a presenting aneurysm had been treated, and finally those who had not been well enough for surgery at the end of their 6-week conservative regimen. All were in relatively good physical health. There was no mortality. Five developed postoperative hemiplegia but all made a total recovery. In these total 102 elective craniotomies there was therefore no mortality and only one per-manent monoparesis, which simply reaffirms the implication of the significant 1953 report of Norl6n and Olivecrona. H The mortality and morbidity have thus been almost totally assigned to the period of medical management which must be considered in greater detail (Table 2) .
Preoperative Management
This consists of pulmonary support when needed, antifibrinolysis, controlled hypotension for those who can tolerate it, and control of ICP if it is needed. Such care requires intensive dedicated individual nursing care by a staff specifically trained in management of the problem. In our experience it is not afforded in a general intensive care unit. The patient with a recent SAH needs, in fact, the intensive neurosurgical care customarily provided to patients immediately after craniotomy.
Management on Admission
Immediate pulmonary support (including intubation) was given if needed. An intravenous catheter was inserted to provide mannitol should the subsequent lumbar puncture pressure prove excessive or should the patient deteriorate as a result of raised ICP. Once the diagnosis of SAH was confirmed by lumbar puncture, intravenous epsilonaminocaproic acid (EACA) was commenced. Angiography was not done until it was believed that the patient was ready for some type of surgical intervention. This could mean a delay of hours, days, or weeks. Recently, in patients with a decreased level of consciousness a computerized tomographic (CT) scan was done to diagnose hematomas. In others it was useful to recognize the source of the hemorrhage and to estimate the size of the ventricles. If the patient was considered suitable for a hypotensive regimen this was started.
Pulmonary Support
Pulmonary support was provided in the routine pattern common to most intensive care areas. In general we used intubation and assistance at the very earliest sign of respiratory difficulty rather than waiting until obvious difficulty was established. The efficiency of respiration and respiratory sup-S. Mullan, K. Hanlon and F. Brown 
A nti fibrinolysis
It is recognized that failure to perform an early angiogram permits treatment by fibrinolysis of some patients whose SAH is due to causes other than cerebral aneurysm, such as an intracerebral hemorrhage which leaks into the subarachnoid space. Since the drug does not cause any known aggravation of any of the recognized causes of SAH, and since it is not certain that angiography is a benign procedure in all patients who have an impaired blood-brain barrier and cerebral spasm, the policy appears valid.
The course of EACA that we prescribed was approximately 48 gm daily for the first 2 weeks, 36 gm daily for the second 2 weeks, and 24 gm daily for the last 2 weeks. Our animal experiments have shown that, in the femoral artery of the dog and in the subarachnoid space of the rabbit, the drug merely delayed rather than prevented fibrinolysis, and that it was most effective during the first week, less effective during the second, and virtually ineffective in preventing lysis beyond the third week. The duration of treatment was therefore quite arbitrary. In this series it has been used for 6 weeks or until the time of surgery, although there was little experimental support for this 6-week duration. The fibrinolytic blood level was checked every few days by the accelerated clot lysis method aiming for a duration in excess of 48 hours. The dose schedule was frequently adjusted downward, especially in later weeks in accordance with these test results. In the later stages, as veins thrombosed, administration was oral. This was sometimes associated with nausea.
Problems with Antifibrinolysis
There are two possible adverse reactions to antifibrinolytic treatment. Since it seems to be increasingly recognized that breakdown products of the red cell are related to severe spasm, it is logical that increased duration of the clot may result in prolonged application of blood breakdown products to the blood vessels in the subarachnoid space and, therefore, to an extended duration, if not an intensification, of the spasm problem. The incidence of deterioration after admission in 25 patients (although only nine died) approximates very closely to the total number who deteriorated and died in the conjoint study. 1' In other words, it is not in excess of the figure in that study. It is not possible, however, to compare accurately with the data in that study the degrees of deterioration, nor the added effect in this series of the concomitant therapeutic hypotension, nor the very intensive nursing care provided at our institution. Thus the possible spasmogenic role of antifibrinolysis cannot be evaluated in this series.
Of greater concern might be the incidence of thrombogenic complications, thrombophlebitis and pulmonary embolism. There were five cases of thrombophlebitis and four of pulmonary embolism among our patients. No thrombophlebitis occurred before the 20th day of treatment, and no pulmonary embolism occurred before the 23rd day of treatment (Table 3) . One patient developed thrombophlebitis on the 22nd day and stopped antifibrinolytic treatment immediately, but had a pulmonary embolism on the 32nd day after SAH and died. None of the other three with pulmonary embolism had a previous thrombophlebitis. Thus only one of four patients with pulmonary emboli had a previously recognized thrombophlebitis, and discontinuance of the drug did not in that one instance prevent a fatal embolism 10 days later. These observations add little to solve the question of the relationship of antifibrinolytic treatment to pulmonary embolism in the management of SAH except to state that the incidence is indeed real but low. One might still speculate as to whether antifibrinolysis promotes pulmonary embolism or, in fact, prevents it by retarding the liberation of leg clots.
Induced Hypotension
The use of hypotension is based upon the rather obvious premise that balloons with lower pressure should burst less easily. Oral medications, intravenous medications, and proximal subtotal carotid ligations have all been used to lower blood pressure. As the series progressed, greater sequential emphasis was placed upon oral medication, proximal carotid ligation, and intravenous medication in that order. Hypotension was applied most energetically immediately after admission, stopped during the phase of spasm or deterioration, and resumed as the patient resumed improvement. In those without deterioration it was maintained throughout. It must be recognized that hypotension should not be used in the drowsy patient nor in the patient developing neurological defect, in both of whom global or regional decrease of blood flow must be presumed. Both need their normal blood pressure.
Of the 97 patients under study, some form of hypotensive control was used in 77 at some stage or stages. They were in Grades 1, 2, or in upper or stable 3. Twenty did not qualify for reduction of pressure at any time. The three different mechanisms of hypotensive control were not ever used simultaneously. *IV = intravenous medication. Blood pressure was not lowered at any time in 20 patients.
Oral medication was used alone in 26, and in combination in another 23. A subtotal clamp alone was used in 13, and in combination in another 26. Intravenous medication was used alone in eight but in combination in 14 ( Table  4 ). The mean duration of oral medication was 15.5 days and the percentage reduction of systolic pressure (as compared to entering pressure or previously known pressure) was (Table 5) . Intravenous Hypotension. This was introduced only late in the series. The current method is as follows. Immediately upon admission trimethaphan camsylate (Arfonad) is given to the bright and alert patient in order to bring the systolic pressure down to a point when symptoms, general or regional, appear. It is then raised instantly to a point 15 mm Hg above this, or to a point which is 30% short of the entering pressure, whichever is higher. Since the entering pressure is not necessarily the patient's basic pressure, the setting may be scaled down on subsequent days once the true blood pressure becomes apparent. If the patient is slightly less than totally alert or if there is any unilateral sign, then the pressure reduction should be less. If some doubt exists at any stage in pressure management as to the degree of reduction the patient might tolerate, then it is best to abandon all attempts to lower pressure. This is based upon the ethical concept that, in serious doubt, it is better that the patient should accept the spontaneous rather than the iatrogenic consequences.
Trimethaphan camsylate is preferred to nitroprusside because in our limited observations it has less effect upon autoregulation and therefore interferes less with blood flow. 2 The dose is quite individual, but 1 to 2 ug/kg/min is not infrequently an adequate initial dose. If, after a few days, tachyphylaxis to the drug develops and more is required to effect an equivalent reduction, then a switch is made to nitroprusside. A progressive increase of the dose of trimethaphan camsylate could progress to the point of pharmacologically dilated and fixed pupils (with consequent clinical confusion to the surgeon) and still fail to control blood pressure.
The dose of nitroprusside is again quite individual, but 2 to 4/ag/kg/min is perhaps a reasonable starting point. An increasing blood pressure in the presence of a dose of nitroprusside that previously held it stable is an important observation. It might mean that the drug is deteriorating under exposure to light. More importantly, it probably means that an increasing ICP or an increasing spasm is creating a demand for a higher pressure.
The situation must be dealt with by investigating the cause and treating it if possible. Mannitol, rather than increased nitroprusside, is usually the answer. Mannitol will reduce ICP, and it should also increase cerebral blood flow. Any hypertonic solution may dilate small blood vessels? These factors must also be considered with administration of trimethaphan camsylate, although tachyphylaxis is the more usual explanation for a rising pressure with that drug.
Throughout the administration of these drugs the intensive care nurse must be in constant attendance. Blood pressure may be taken intra-arterially to begin with, until stabilized, or by cuff every few minutes. Once the dose is stabilized, it is taken every 15 minutes, or more often if the nurse observes any change in the patient's condition. One patient has been managed thus for 3 weeks, but most have been managed for a few days at a time. There has been no evidence of toxicity of the drug.* The main problem with this treatment has been maintenance of the very intensive care that is entailed. The level of blood pressure that is tolerated must always be related to the patient's alertness and neurological signs, and must always therefore depend upon good clinical judgment. If doubt exists, as it may during necessary sleep, then hypotension is reduced or discontinued.
Oral Hypotension. Oral hypotensive medication has been used with decreasing frequency because of the inability to reverse its effect in the face of a patient's deteriorating clinical condition and the great difficulty in securing and maintaining a stable level. Initial management by potent, longacting oral medications, such as Aldomet (methyldopate hydrochloride), was discontinued early in the series. Thorazine (chlorpromazine), to control restlessness and afford some mild hypotension, has been used throughout, often as occasion arises. Reserpine has been more commonly employed as the patient improved from the period of spasm. Hydralazine has also been employed, usually in the later weeks. Aldomet has also *Subsequent to completion of this series we encountered a patient with a toxic response characterized by a falling PaO2, respiratory difficulty, and confusion. These changes rapidly reverted when the nitroprusside was stopped.
been added later for those few who refused intracranial surgery and occasionally for those who had a serious previous hypertension.
Subtotal Carotid Occlusive Hypotension. Subtotal carotid occlusion has the advantages of. easy reversibility and a documented efficiency in reducing pressure. It has the theoretical advantages that it does not alter vascular autoregulation and demands only a local rather than a total lowering of perfusion pressure. It also demands less attention from the nursing staff. Its disadvantages are that embolization of the carotid artery and infection at the site of insertion into the neck are both possible. Until the introduction of intravenous medication late in the series this method was used regularly as soon as possible after admission. It is now used after several days of intravenous medication before toxicity appears. For long-term use it is less inconvenient to the patient than the nitroprusside method with its frequent blood pressure readings.
Subtotal carotid occlusion was carried out in patients with aneurysms suitably located. Angiography was performed as soon as it was thought that the patient could tolerate the procedure. This could be on the first or any subsequent day. The alertness of the patient, freedom from neurological deficit, ability to tolerate manual carotid compression and, as a rule, freedom from severe cerebral spasm were all important in the choice of this procedure. Since pounding retro-orbital pain and third-nerve palsy were regarded as a sign of impending rupture, the situation was treated as an emergency if these were present (again if the above conditions for hypotensive therapy were fulfilled). At the end of the series, the instant use of trimethaphan camsylate or nitroprusside, to relieve these severe headaches and the danger of bursting, took care of the emergency aspect of the regimen. Internal carotid and middle cerebral aneurysms were both regarded as suitable for subtotal occlusion, and it was used once for an anterior communicating aneurysm.
A Selverstone carotid clamp was usually applied under local anesthesia unless the patient was too nervous. It was inserted low in the neck between the two heads of the sternomastoid bone. In the initial case it was adjusted with a catheter in the superficial temporal artery, which was first closed fully and then opened until pulsations occurred. Later it was adjusted by manual palpation of the carotid artery, high in the neck, to detect a trace of pulsation as the clamp opened minimally. 6 The clamp was then adjusted twice daily because of a spontaneous tendency to reopen. It was opened immediately if the patient's condition deteriorated. It was kept subtotally occluded during craniotomy and removed after surgery. In those patients in whom it was kept in place more than 2 weeks before surgery, it was opened and the stem was removed after surgery but the box was left in situ. Surgical removal increases in difficulty with the duration of employment.
Problems of the Subtotal Carotid Clamp
The early signs of deterioration (arm drift, word impairment, or drowsiness) caused the clamp to be reopened fully in five patients. In two patients the signs then failed to progress and both ultimately did very well, in one the signs improved but the patient later deteriorated suddenly after injudicious medical hypotensive management, and in two the signs, minimal at the time of opening, slowly progressed to the point of hemiplegia despite the open clamp. Both of the latter patients ultimately made an incomplete recovery from their neurological deficit.
There were two instances of embolism. In one an inexperienced team member had adjusted the clamp 12 hours previously; presumably it was closed totally instead of subtotally because, when it was opened, the patient sustained an immediate hemiplegia from which she made an incomplete recovery. The other patient had a previous history of several psychiatric hospitalizations. On the second day after clamping she unscrewed and removed the stem of her clamp, and subsequently refused craniotomy and removal of the clamp. On the 23rd day routine examination showed that the ipsilateral pupil reacted poorly to light; on further questioning the patient stated that she had been aware of visual loss on the previous day. Apparently she had suffered retinal embolism. She then consented to craniotomy and removal of the clamp and left hospital in good condition, but with impaired visual acuity in that eye. One patient had a mild infection about the stem which cleared upon removal of the clamp. In one patient with furunculosis and in another with normal skin there was no immediate in-S. Mullan, K. Hanlon and F. Brown (Table 6 ).
Blood Pressure and Rebleeding
Although the mechanism by which hypotension was achieved in these cases was quite varied, one observation that may be meaningful is the relationship between rebleeding and lack of pressure control. Five of the six patients who rebled did not have hypotensive control. One had a clamp applied but it was opened as her clinical level fell. The remaining four never qualified for pressure control. A partial clamp was applied to the left common carotid artery of the sixth patient whose anterior communicating aneurysm filled only from the left side. Within a few minutes of its application he rebled and died. In retrospect, this was a conceptual error. The application of the clamp simply drew an increased flow of blood across the base of the aneurysm. Of the six patients who died of rebleeding, two had a lower blood pressure at the time of rebleeding than on admission, in two it was similar, and in two it was higher than on admission (Table  7) . Thus, no patient rebled and died who was on antifibrinolytic medication and who had effective blood pressure control. The multiplicity of hypotensive methods used reflects our efforts to find one that was safe, effective, and simple. 
Control of Intracranial Pressure
Perfusing pressure and bursting pressure are directly related, and any attempt to lower the ICP raises the bursting pressure. Therefore, in a bright alert patient a raised ICP is good. Neither external drainage nor shunting procedures have been employed in this series. In a previous experience, the timing of ventricular catheter placement was so closely related to rebleeding on two occasions that a causal relationship (perhaps unjustified) was feared. Once a shunt is placed, there is no longer any control of pressure. Control exists with external drainage but the temptation to lower pressure might be too great and the risk of infection is too high. Mannitol in most situations relieves the pressure and at the same time increases blood flow? Pressure was measured as often as necessary (even several times daily) by lumbar puncture, and mannitol was given at a rate that kept the ICP close to 300 mm H20. Slow infusion of one, two, or even three bottles (100 gm each) per day is well tolerated and effective. In all instances and especially with higher doses, central venous pressure, and blood and urine electrolytes and creatinine were watched very closely. A high intake of fluid was necessary.
Problems in Clinical Deterioration
There were 18 cases with deterioration not associated with the use of the carotid clamp. One patient had a fatal gastrointestinal hemorrhage. Two had intracerebral hematomas. One of these deteriorated rapidly within hours of being admitted in an alert state, and fairly prompt diagnosis did not save him. The other deteriorated progressively. On the fifth day the hematoma was removed, and she improved slowly but ultimately developed pulmonary embolism on the 32nd day and died.
In the other 15 patients, six of whom died, there was progressive decrease in cerebral perfusion and progressive increase in ICP. These usually co-existed. We have come to regard a rising blood pressure as a serious event. In many instances it is a response to a rising ICP. Control of the ICP usually results in spontaneous improvement in the blood pressure and in the patient's condition. Lowering the blood pressure by direct pharmacological means without also lowering ICP reduces the perfusion pressure and causes deterioration in the patient's condition. The following case illustrates the role of increasing pressure.
This 29-year-old normotensive woman had two aneurysms on the right, one at the posterior communicating junction and another at the bifurcation. There was an intense spasm which made the use of a carotid clamp seem unwise. Her systolic blood pressure was therefore kept at about 100 mm Hg with nitroprusside. On the morning of the sixth day after hemorrhage she was well. At 5:30 p.m., she was unresponsive with a fixed right pupil and was thought to have had a recurrent hemorrhage. A quick appraisal of her chart showed that she had had increasing headache, increasing restlessness, and a rising blood pressure since shortly before noon. Increasing doses of nitroprusside temporarily brought the pressure down only to be followed by a new rise and a yet higher dose of nitroprusside was administered. Decreasing alertness was soon added to the clinical picture. It was thus apparent that the problem was a rising ICP with decreasing perfusion which was erroneously treated by nitroprusside. A bottle of mannitol (100 gm) was quickly given, and within an hour the patient was sitting up in bed (somewhat drowsily) having supper. A similar but lesser deterioration occurred on the seventh, ninth, and tenth days. Hypotensive treatment was later resumed as spasm relaxed. Both aneurysms were clipped on the 23rd day after almost total disappearance of spasm. She made a complete recovery.
Definitive Surgical Treatment
Surgical treatment of the aneurysm was carried out when the patient had made a good recovery from the initial hemorrhage. Conventional techniques were employed. Thrombosis was reserved for giant aneurysms. All patients were quite alert, depending on the neurological defect they had sustained. Alertness in a patient recovering from a catastrophic anterior communicating aneurysm or from aphasia was not the same as alertness in one who had sustained no damage. It was a qualitative state characterized by an absence of drowsiness and by an appropriate relationship to the environment. At least 10 days had elapsed in all patients since the hemorrhage, and in almost all instances the cerebrospinal fluid (CSF) pressure at lumbar puncture was no greater than 200 mm H20. Infrequently a pressure above this figure was accepted but never above 250 mm H20. Abnormal neurological signs had stabilized or, as a rule, were improving by the time the CSF pressure was satisfactory. Occasionally, angiography had not been performed until immediately before surgery. If it had been performed earlier it was repeated before surgery to ensure that an unsuspected spasm did not exist, or to verify that improvement had occurred in a previously recognized spasm. This had always improved by the time the patient had recovered to our criteria in all other respects. The insistence upon a CSF pressure below 200 mm H20, and not angiographic spasm, was the most common cause for delay.
In all instances on the day before surgery the blood pressure was temporarily reduced by trimethyl camsylate until symptoms or signs developed ("Arfonad test"). This was usually in the range of 60 to 80 mm Hg (systolic). Symptoms mostly consisted of a subjective sense of weakness and dizziness. This test was carried out with the clamp (if applied) in the subtotally occluded position.
The outstanding factor that was believed to be responsible in securing good surgical results was this insistence on a good clinical state and a low ICP (slack brain). The elasticity in ICP provided by this low reading permitted the patient to sustain a significant increase in ICP in the postoperative period without hazard. The mental alertness gave some assurance, in the absence of blood flow studies and of methods of estimating cerebral edema, th~tt cerebral blood flow was probably adequate and that cerebral edema was probably mild or absent.
Another factor of probable importance was the use of 100 gm mannitol given, after the bone flap was turned, to allow the slack brain to retract spontaneously. Mannitol was not given before the bone was turned lest hemorrhage in association with a torn dura could fill an iatrogenically enlarged subdural space. Thus mechanical retraction was kept to a minimum in order to prevent tissue hypoxia and subsequent swelling. All exposed brain was temporarily covered by a layer of Gelfoam, which helped distribute any pressure of retraction and kept the brain quite moist. In an effort to prevent postoperative spasm, tlle subarachnoid spaces were not widely ope, ned in a manner which would allow access of (spasmogenic) blood to the vessel surfaces. Manipulation of the vessels was kept to a minimum. Access to the anterior communicating aneurysm was usually achieved by subpial removal of a very small amount of overlying cortex, permitting identification of the aneurysm and its vessels through the undisturbed pia. The pia was dissected from the neck only immediately before clipping. A similar approach was used for middle cerebral aneurysms, removing a very small amaunt of overlying frontal or temporal cortex. Occasionally, a small portion of overlying anteromedial temporal lobe adherent to a posterior communicating aneurysm was removed to permit undisturbed access to that aneurysm. The volume of removal i~a each instance was quite small and usually in the range of 1 to 2 ml. Magnification was used infrequently.
At the Lime of dissection of the aneurysm, the systolic blood pressure was lowered only to that figure which the preoperative hypotensive test ("Arfonad test") showed the patient could safely tolerate. Operative rupture was rare, unlike our previous experience when we operated soon after the initial hemorrhage. These "late" aneurysms tolerated much more surgical manipulation and did not necessarily bleed when the related clot was disturbed.
Immediately after the aneurysm was clipped, the subtotally closed carotid clamp in the neck was opened. For 24 hours a subdural drain was used in order to drain all (spasmogenic) blood away from the exposed cerebral vessels. The Selverstone clamp was removed from the artery at the end of the procedure, or the stem only was removed if the clamp had been left longer than 2 weeks and was somewhat adherent.
Postoperative Care
Despite the good condition of our patients and the specific steps taken to prevent spasm, there was subsequent hemiparesis or hemiplegia in eight cases. Their care and satisfactory resolution is the subject of a separate paper. TM Our current specific regimen consists in producing a high perfusion pressure by raising blood pressure and lowering ICP. Dopamine in the presence of a high central venous pressure will keep the blood pressure up. Mannitol will lower ICP thereby raising perfusion pressure, and will probably also dilate blood vessels, xs All patients had postoperative angiograms performed. In two cases of anterior communicating aneurysms the angiograms showed some slippage of the clip. One patient had had a mild rebleed. This was one of the few who bled rather vigorously at operation, and it was elected not to disturb the precarious position of the clip. Six months later there was no change in the appearance of the residual aneurysm neck, and the patient has had no further trouble in 3 years. The other patient was reoperated on and the bulging aneurysm neck was sealed with thrombogenic wire.
Discussion
Although our total management mortality of 15 contrasts favorably with the spontaneous history of the disease, it shows that much room remains for further improvement. The combination of effective hypotension and EACA therapy was not associated with rebleeding. On the other hand, five of the six patients who rebled simply could not tolerate hypotension. If they could not tolerate hypotension the question arises whether they could have tolerated an earlier operation. Perhaps an earlier operative approach might have saved four of the six (excluding those who died on the fourth and sixth day). Perhaps the insistence upon a CSF pressure below 200 mm H20 is unrealistic, perhaps 250 mm H20 would be acceptable. However, one must consider the possibility that even if a policy of earlier operation did save these four, then they, and an unknown number of the 25 who deteriorated, might have sustained a higher incidence of lasting hemiplegia with or without dysphasia. When one considers the total category of major catastrophe, the difference in degree between a total or a subtotal one (that is, between death and catastrophic neurological deficit) is not necessarily great. It is thus not clear that a policy of earlier operation would bring better results, but it seems a logical step to explore in the next phase of our endeavors.
In the nine patients who deteriorated and died, probably three deaths were inevitable, but in three an excessively aggressive hypotension cannot be totally exonerated. The patient who died of a gastrointestinal hemorrhage might now be saved by the use of the new H2 histamine blockers.I" One who died of pulmonary embolism following thrombophlebitis might now be saved by use of an automatic intermittent leg compression apparatus.$ In our recent experience of two patients this apparatus has relieved symptoms of thrombophlebitis within 24 hours, although they came back temporarily in one when use of the apparatus was temporarily discontinued. One of the two patients who died of cerebral hematoma might have been saved by an earlier computerized tomography diagnosis.
Our main efforts in the next phase will be directed toward lowering the mortality and morbidity of those who deteriorate while awaiting surgery.
Two of the elements of our system, pulmonary care and antifibrinolysis, have been standard throughout this period of study and we see no need to alter them. Control of ICP by mannitol is relatively simple to achieve; the problem lies in judgment as to when to intervene. Our rule at the moment is that a moderately high ICP is a good shield against rebleeding, provided that the patient is alert. If we feel that a deterioration is due tSince completing this series we have had a patient with an arteriovenous frontal hematoma who developed serious gastric hemorrhage despite the use of Hz histamine blocker. :~Venodyne automatic intermittent leg compression apparatus manufactured by Lyne-Nicholson, Inc., 1000 Highland Avenue, Needham Heights, Massachusetts.
to an increasing ICP, rather than to an increase in cerebrovascular resistance, then we lower the ICP, thereby accepting a somewhat greater chance of rebleeding. A continuous ICP recording, rather than an intermittent one, and simultaneous blood flow readings would undoubtedly sharpen the quality of judgment. Fortunately mannitol lowers ICP and also specifically enhances cerebral blood flow. This dual function and the ability to set the desired pressure level make it superior to CSF shunting and to external CSF drainage (which carries an additional risk of infection).
Control of blood pressure remains the least satisfactory of our supportive measures. In the first place it is not applicable to those who have poor blood flow. Secondly there is no single good method of reducing blood pressure over several weeks. Trimethyl camsylate shows an early tachyphylaxis. Nitroprusside may in time develop cyanide toxicity. A partially closed clamp is not suitable for all aneurysms and may develop complications of embolism and infection. Thus at present we may in any one patient use all three methods for a short period each. A better pharmacological agent, a more sophisticated clamp, and frequent cerebral blood flow measurements might all be expected to improve results. A drug that could effectively prevent or relieve spasm would, of course, permit much earlier surgery and make much of this detailed medical support obsolete.
